Design, synthesis & biological evaluation of some novel quinazolinone scaffolds

Medicinal Chemistry

Volumn 8, Issue 2, 2012, Pages 182-192

  Modh, Rahul P ^a   Patel, Amit C ^b   Chikhalia, Kishor H ^a  

^a GUJARAT UNIVERSITY   (India)

^b VEER NARMAD SOUTH GUJARAT UNIVERSITY   (India)

Author keywords

Antibacterial study; Antifungal study; Dimethoxyphenyl ethanamine; Quinazolin 4(3H) one; Semicarbazide; Styryl; Thiophen 2 ethylamine

Indexed keywords

3 [(THIOPHEN 2 YL)ETHYL] 2 (2 CHLOROSTYRYL)QUINAZOLIN 4(3H) ONE; 3 [(THIOPHEN 2 YL)ETHYL] 2 (3,4,5 TRIMETHOXYSTYRYL)QUINAZOLIN 4(3H) ONE; 3 [(THIOPHEN 2 YL)ETHYL] 2 (4 FLOUROSTYRYL)QUINAZOLIN 4(3H) ONE; 3 [(THIOPHEN 2 YL)ETHYL] 2 (4 HYDROXY 3 METHOXYSTYRYL)QUINAZOLIN 4(3H) ONE; 3 [(THIOPHEN 2 YL)ETHYL] 2 (4 HYDROXYSTYRYL)QUINAZOLIN 4(3H) ONE; 3 [(THIOPHEN 2 YL)ETHYL] 2 (4 METHOXYSTYRYL)QUINAZOLIN 4(3H) ONE; 3 [(THIOPHEN 2 YL)ETHYL] 2 [4 (DIMETHYLAMINO)STYRYL]QUINAZOLIN 4(3H) ONE; ANTIINFECTIVE AGENT; N1 (2 CHLOROPHENYL) N3 [3 [(3,4 DIMETHOXYPHENYL 2 YL)ETHYL] 4(3H) QUINAZOLONE 2 YL]ACETONYL SEMICARBAZIDE; N1 (2 FLOUROPHENYL) N3 [3 [(3,4 DIMETHOXYPHENYL 2 YL)ETHYL] 4(3H) QUINAZOLONE 2 YL]ACETONYL SEMICARBAZIDE; N1 (2 METHYLPHENYL) N3 [3 [(3,4 DIMETHOXYPHENYL 2 YL)ETHYL] 4(3H) QUINAZOLONE 2 YL]ACETONYL SEMICARBAZIDE; N1 (3 CHLOROPHENYL) N3 [3 [(3,4 DIMETHOXYPHENYL 2 YL)ETHYL] 4(3H) QUINAZOLONE 2 YL]ACETONYL SEMICARBAZIDE; N1 (3 FLOUROPHENYL) N3 [3 [(3,4 DIMETHOXYPHENYL 2 YL)ETHYL] 4(3H) QUINAZOLONE 2 YL]ACETONYL SEMICARBAZIDE; N1 (3 METHYLPHENYL) N3 [3 [(3,4 DIMETHOXYPHENYL 2 YL)ETHYL] 4(3H) QUINAZOLONE 2 YL]ACETONYL SEMICARBAZIDE; N1 (4 CHLOROPHENYL) N3 [3 [(3,4 DIMETHOXYPHENYL 2 YL)ETHYL] 4(3H) QUINAZOLONE 2 YL]ACETONYL SEMICARBAZIDE; N1 (4 FLOUROPHENYL) N3 [3 [(3,4 DIMETHOXYPHENYL 2 YL)ETHYL] 4(3H) QUINAZOLONE 2YL]ACETONYL SEMICARBAZIDE; N1 (4 METHYLPHENYL) N3 [3 [(3,4 DIMETHOXYPHENYL 2 YL)ETHYL] 4(3H) QUINAZOLONE 2 YL]ACETONYL SEMICARBAZIDE; N1 (PHENYL) N3 [3 [(3,4 DIMETHOXYPHENYL 2 YL)ETHYL] 4(3H) QUINAZOLONE 2 YL]ACETONYL SEMICARBAZIDE; QUINAZOLINONE DERIVATIVE; SEMICARBAZIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; ASPERGILLUS NIGER; BACILLUS SUBTILIS; BROTH DILUTION; CANDIDA ALBICANS; CARBON NUCLEAR MAGNETIC RESONANCE; CLINICAL EVALUATION; DRUG DESIGN; DRUG SYNTHESIS; ESCHERICHIA COLI; IN VITRO STUDY; INFRARED SPECTROSCOPY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SALMONELLA TYPHI; STAPHYLOCOCCUS AUREUS;

EID: 84861920293     PISSN: 15734064     EISSN: 18756638     Source Type: Journal    
DOI: 10.2174/157340612800493610     Document Type: Article

References (54)

1. Nikaido, H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science, 1994, 264, 382-388 (Pubitemid 24178901)
2. Spratt, B.G. Resistance to antibiotics mediated by target alterations. Science, 1994, 264, 388-393 (Pubitemid 24986723)
3. Silver, L.L. Challenges of antibacterial discovery. Clin. Microbiol. Rev., 2011, 24, 71-109
4. Nathan, C. Antibiotics at the crossroads. Nature, 2004, 431, 899-902 (Pubitemid 39434399)
5. Dawane, B.S.; Konda, S.G.; Mandawad, G.G.; Shaikh, B.M. Poly(ethylene glycol) (PEG-400) as an alternative reaction solvent for the synthesis of some new 1-(4-(4-chlorophenyl)-2-thiazolyl)-3-aryl-5-(2-butyl-4-chloro-1H-imidazol- 5yl)-2-pyrazolines and their in vitro antimicrobial evaluation. Eur. J. Med. Chem., 2010, 45, 387-392
6. Boyd, D.B. Chemistry and Biology, R.B. Morin, M. Gorman (Eds.), ed.; Academic Press, New York, 1982
7. Alexandre, F.-R.; Berecibar, A.; Wrigglesworth, R.; Besson, T. Novel series of 8H-quinazolino[4,3-b]quinazolin-8-ones via two Niementowski condensations. Tetrahedron, 2003, 59, 1413-1419 (Pubitemid 36183615)
8. Xia, Y.; Yang, Z.-Y.; Hour, M.-J.; Kuo, S.-C.; Xia, P.; Bastow, K.F.; Nakanishi, Y.; Nampoothiri, P.; Hackl, T.; Hamel, E.; Lee, K.-H. Antitumor agents. Part 204: synthesis and biological evaluation of substituted 2-Aryl quinazolinones. Bioorg. Med. Chem. Lett., 2001, 11, 1193-1196 (Pubitemid 32406083)
9. Barker, A.J.; Gibson, K.H.; Grundy, W.; Godfrey, A.A.; Barlow, J.J.; Healy, M.P.; Woodburn, J.R.; Ashton, S.E.; Curry, B.J.; Scarlett, L.; Henthorn, L.; Richards, L. Studies leading to the identification of ZD1839 (iressa™): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer. Bioorg. Med. Chem. Lett., 2001, 11, 1911-1914 (Pubitemid 32675316)
10. Sarvanan, J.; Manjunatha, K.S. Cyclisation of unsaturated ketones. Ind. J. Heterocycl. Chem., 1998, 8, 55-61
11. Rosowsky, A.; Papoulis, A.T.; Forsch, R.A.; Queener, S.F. Synthesis and antiparasitic and antitumor activity of 2,4-Diamino-6-(arylmethyl)-5,6,7,8- tetrahydroquinazoline analogues of piritrexim1. J. Med. Chem., 1999, 42, 1007-1017 (Pubitemid 29153430)
12. Jantová, S.; Stankovsk, .; pirková, K. In vitro antibacterial activity of ten series of substituted quinazolines. Biologica. Bratislava, 2004, 59, 741-752 (Pubitemid 40346268)
13. Zhou, Y.; Murphy, D.E.; Sun, Z.; Gregor, V.E. Novel parallel synthesis of N-(4-oxo-2-substituted-4H-quinazolin-3-yl)-substituted sulfonamides. Tetrahedron Lett., 2004, 45, 8049-8051 (Pubitemid 39303642)
14. Panneerselvam, P.; Rather, B.A.; Ravi Sankar Reddy, D.; Ramesh Kumar, N. Synthesis and anti-microbial screening of some Schiff bases of 3-amino-6,8-dibromo-2-phenylquinazolin-4(3H)-ones. Eur. J. Med. Chem., 2009, 44, 2328-2333
15. Bartroli, J.; Turmo, E.; Algueró, M.; Boncompte, E.; Vericat, M.L.; Conte, L.; Ramis, J.; Merlos, M.; García-Rafanell, J.; Forn, J. New azole antifungals. 3. Synthesis and antifungal activity of 3-substituted-4(3H)- quinazolinones. J. Med. Chem., 1998, 41, 1869-1882 (Pubitemid 28248662)
16. Chandrika, P.M.; Yakaiah, T.; Rao, A.R.; Narsaiah, B.; Reddy, N.C.; Sridhar, V.; Rao, J.V. Synthesis of novel 4,6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines. Eur. J. Med. Chem., 2008, 43, 846-52 (Pubitemid 351447327)
17. Dinakaran, M.; Selvam, P.; Clercq, E.D.; Sriidhar, S.K. Synthesis, antiviral and cytotoxic activity of 6-bromo-2,3-disubstituted 4(3H)-quinazolinones. Biol. Pharm. Bull., 2003, 26, 1278-1282 (Pubitemid 41656562)
18. Abdel-Rahman, T.M. Synthesis of some new biologically active 2,3-disubstituted quinazolin-4-ones. Heterocyclic Commun., 1997, 3, 535-543 (Pubitemid 127526153)
19. Aono, T.; Marui, S.; Itoh, F.; Yamooka, M.; Nakao, M. Heterocyclic compounds, their production and use. US. Patent No. US 5753664, 1998
20. Kumar, P.; Nath, C.; Bhargava, K.P.; Shanker, K. Synthesis and antiparkinsonian activity of styryl quinazolones. Pharmazie, 1982, 37, 802 (Pubitemid 13195950)
21. Pandey, S.K.; Singh, A.; Nizamuddin. Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-triazole, [1,2,4]-triazine and [1,2,4,5]-tetrazine rings. Eur. J. Med. Chem., 2009, 44, 1188-1197
22. Ibrahim, M.K. Synthesis of novel substituted mercaptoquinazolinones of expected anticonvulsant activity. Al-Azhar J. Pharm. Sci., 1998, 22, 9-12
23. Ishikawa, M.; Azuma, H.; Eguchi, Y.; Ito, S.; Naito, T.; Ebisawa, H.; Kotoku, I. Structure-Activity relationships and pharmacological properties of a new hypotensive agent (Eg 1088). J. Pharmacobio-Dyn., 1982, 5, 8
24. Mishra, P.; Paneerselvam, P.; Jain, S. A Few 2-Methylquinazolin-4(3H)- ones as antimicrobial agents. J. Indian Chem. Soc., 1995, 72, 559-560
25. Mishra, P.; Gupta, P.N.; Shakya, A.K. Synthesis of some Schiff bases of 3-amino-2-methylquinazolin-4(3H)-ones and their antimicrobial activities. J. Indian Chem. Soc., 1991, 68, 618-619
26. Kulkarni, Y.D.; Rowhani, A. Synthesis of 2-methyl-6,8-substituted-3- [substituted-aminoacetyl]-4(2H)-quinazolinone as potential antimicrobial agents. J. Indian Chem. Soc., 1990, 67, 46-47
27. Mohamed, M.S.; Kamel, M.M.; Kassem, E.M.; Abotaleb, N.; Abd El-Moez, S.I.; Ahmed, M.F. Novel 6,8-dibromo-4(3H)quinazolinone derivatives of anti-bacterial and anti-fungal activities. Eur. J. Med. Chem., 2010, 45, 3311-9
28. Chandra, T.; Garg, N.; Kumar, A. Synthesis of Sulpha Drug Quinazolin -4-one Derivatives and Their Evaluation for Antiinflammatory Activity. World J. Chem., 2009, 4, 210-218
29. Kiruthiga, B.; Ilango, K.; Valentina, P.; Umarani, N.; Patel, R. Synthesis of some new 2-substituted quinazolin-4-one derivatives and their biological activities. Int. J. PharmTech Res., 2009, 1, 1503-1506
30. Raghavendra, N.M.; Gurubasavarajaswamy, P.M.; Nagaranavile, K.S.; Parameshwaran, T. Antitumor actions of imidazolyl-(4-oxoquinazolin-3(4H)-yl)- acetamides against Ehrlich Ascites Carcinoma. Arch Pharm Res., 2009, 32, 431-6
31. Chandrikaa, P.M.; Yakaiahb, T.; Narsaiah, B.; Sridharc, V.; Venugopalc, G.; Rao, J .V.; Kumar, K.P.; Murthyd, U.S.N.; Rao, A.R.R. Synthesis leading to novel 2,4,6-trisubstituted quinazoline derivatives, their antibacterial and cytotoxic activity against THP-1, HL-60 and A375 cell lines. Indian J. Chem. B, 2009, 48B, 840-847
32. Marcelli, C.; Chappard, D.; Rossi, J.F.; Jaubert, J.; Alexandre, C.; Dessauw, P.; Baldet, P.; Bataille, R. Histologic evidence of an abnormal bone remodeling in B-cell malignancies other than multiple myeloma. Cancer, 1988, 62, 1163-1170
33. Ashcroft, A.J.; Davies, F.E.; Morgan, G.J. Aetiology of bone disease and the role of bisphosphonates in multiple myeloma. Lancet Oncol., 2003, 4, 284-292 (Pubitemid 36592496)
34. Jung, F.H.; Pasquet, G.; Lambert-Van Der Brempt, C.; Lohmann, J.J.M.; Warin, N.; Renaud, F.; Germain, H.; De Savi, C.; Roberts, N.; Johnson, T.; Dousson, C.; Hill, G.B.; Mortlock, A.A.; Heron, N.; Wilkinson, R.W.; Wedge, S.R.; Heaton, S.P.; Odedra, R.; Keen, N.J.; Green, S.; Brown, E.; Thompson, K.; Brightwell, S. Discovery of novel and potent thiazoloquinazolines as selective Aurora A and B kinase inhibitors. J. Med. Chem., 2006, 49, 955-970 (Pubitemid 43221644)
35. Hennequin, L.F.; Allen, J.; Breed, J.; Curwen, J.; Fennell, M.; Green, T.P.; Lambert-Van Der Brempt, C.; Morgentin, R.; Norman, R.A.; Olivier, A.; Otterbein, L.; Plé, P.A.; Warin, N.; Costello, G. N-(5-chloro-1,3- benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl) ethoxy] -5-(tetrahydro-2H-pyran- 4-yloxy)quinazolin-4-amine, a novel, highly selective, orally available, dual-specific c-Src/Abl kinase inhibitor. J. Med. Chem., 2006, 49, 6465-6488 (Pubitemid 44657442)
36. Al-Rashood, S.T.; Aboldahab, I.A.; Nagi, M.N.; Abouzeid, L.A.; Abdel-Aziz, A.A.M.; Abdel-hamide, S.G.; Youssef, K.M.; Al-Obaid, A.M.; El-Subbagh, H.I. Synthesis, dihydrofolate reductase inhibition, antitumor testing, and molecular modeling study of some new 4(3H)-quinazolinone analogs. Bioorg. Med. Chem., 2006, 14, 8608-8621 (Pubitemid 44667527)
37. Wakeling, A.E.; Guy, S.P.; Woodburn, J.R.; Ashton, S.E.; Curry, B.J.; Barker, A.J.; Gibson, K.H. ZD1839 (Iressa): An orally active inhibitor of epidermal growth factor signaling with potential for cancer therapy. Cancer Res., 2002, 62, 5749-5754 (Pubitemid 35204731)
38. Janlova, S.; Urbancikova, M.; Maliar, T.; Mikulasova, M.; Ranko, P.; Cipak, L.; Kubikova, J.; Stankovsky, S.; Spirkova, K. Biological activity of some 4-anilinoquinazolines: cytotoxic, genotoxic and antiprotease effects, induction of necrosis and changes of actin cytoskeleton. Neoplasma, 2001, 48, 52-60 (Pubitemid 32167707)
39. Bridges, A.J.; Zhou, H.; Cody, D.R.; Rewcastle, G.W.; McMichael, A.; Showalter, H.D.H.; Fry, D.W.; Kraker, A.J.; Denny, W.A. Tyrosine kinase inhibitors. 8. An unusually steep structure-activity relationship for analogues of 4-(3-bromoanilino)-6,7-dimethoxyquinazoline (PD 153035), a potent inhibitor of the epidermal growth factor receptor. J. Med. Chem., 1996, 39, 267-276
40. Jantová, S.; Rueková, L.; pirková, K.; Stankovsk, . Cytotoxic effect of substituted tetrazolo-[1,5-c]quinazolines on HeLa cells. Biologia, 1997, 52, 445-450
41. Maroun, J. Clinical response to trimetrexate as sole therapy for nonsmall cell lung cancer. Semin. Oncol., 1988, 15, 17-21
42. Sielecki, T.M.; Johnson, T.L.; Liu, J.; Muckelbauer, J.K.; Grafstrom, R.H.; Cox, S.; Boylan, J.; Burton, C.R.; Chen, H.; Smallwood, A.; Chang, C.H.; Boisclair, M.; Benfield, P.A.; Trainor, G.L.; Seitz, S.P. Quinazolines as cyclin dependent kinase inhibitors. Bioorg. Med. Chem. Lett., 2001, 11, 1157-1160 (Pubitemid 32406074)
43. Patel, R.B.; Chikhalia, K.H.; Pannecouque, C.; Clercq, E.d. Synthesis of novel PETT analogues: 3,4-dimethoxy phenyl ethyl 1,3,5-triazinyl thiourea derivatives and their antibacterial and anti-HIV studies. J. Braz. Chem. Soc., 2007, 18, 312-321
44. Murugan, V.; Padmavathy, N.P.; Sharma, S.V. Synthesis of some quinazolinone derivatives as possible anticancer agent. Ind. J. Heterocycl. Chem., 2003, 13, 143-146 (Pubitemid 39295821)
45. Errede, L.A.; Martinucci, P.D.; McBrady, J.J. Acylanthranils. 9. Influence of hydrogen bonding on the reaction of acetylanthranil with ammonia. J. Org. Chem., 1980, 45, 3009-3017
46. Alafeefy, A.M.; El-Azab, A.S.; Mohamed, M.A.; Bakhat, M.A.; Abdel-Hamid, S.G. Synthesis of some new substituted iodoquinazoline derivatives and their antimicrobial screening. J. Saudi Chem. Soc., 2011, 15, 319-325
47. Kumar, A.; Sharma, S.; Bajaj, K.; Bansal, D.; Sharma, S.; K K Saxena; Lata, S.; Gupta, B.; Srivastava, V.K. Synthesis and antiinflammatory, analgesic, ulcerogenic and cyclooxegenase activity of novel quinazolinyl-2-pyrazolines. Indian J. Chem. B, 2003, 42B, 1979-1984
48. Güngör, T.; Chen, Y.; Golla, R.; Ma, Z.; Corte, J.R.; Northrop, J.P.; Bin; Dickson, J.K.; Stouch, T.; Zhou, R.; Johnson, S.E.; Seethala, R.; Feyen, J.H.M. Synthesis and Characterization of 3-Arylquinazolinone and 3-Arylquinazolinethione derivatives as selective estrogen receptor beta modulators. J. Med. Chem., 2006, 49, 2440-2455
49. Kamal, A.; Vijaya Bharathi, E.; Janaki Ramaiah, M.; Dastagiri, D.; Surendranadha Reddy, J.; Viswanath, A.; Sultana, F.; Pushpavalli, S.N.C.V.L.; Pal-Bhadra, M.; Srivastava, H.K.; Narahari Sastry, G.; Juvekar, A.; Sen, S.; Zingde, S. Quinazolinone linked pyrrolo[2,1-c][1,4]benzodiazepine (PBD) conjugates: Design, synthesis and biological evaluation as potential anticancer agents. Bioorg. Med. Chem., 2010, 18, 526-542
50. Patanaik, J.M.; Bhatta, D. Synthesis and fungicidal activity of 3-aryl-2-(4'-aryl thiazol-2'-ylaminomethl quinazol-4-(3H)-ones. Indian J. Chem. B, 1998, 37(B), 1304
51. Jiang, J.B.; Hesson, D.P.; Dusak, B.A.; Dexter, D.L.; Kang, G.J.; Hamel, E. Synthesis and biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization. J. Med. Chem., 1990, 33, 1721-1728 (Pubitemid 20180634)
52. Chavan, A.A.; Pai, N.R. Synthesis and biological activity of Nsubstituted-3-chloro-2-azetidinones. Molecules, 2007, 12, 2467-2477
53. Aylwaed, F.; Rao, C.V.N. Use of hydrazine as a reducing agent for unsaturated compounds: II. The hydrogenation of elaidic and ricinoleic acids. J. Appl. Chem. (Londen), 1956, 6, 559
54. Patel, D.H.; Chikhalia, K.H.; Shah, N.K.; Patel, D.P.; Kaswala, P.B.; Buha, V.M. Design, synthesis and antimicrobial study of some pyrimidine derivatives. Pharm. Chem. J., 2010, 44, 94-98.